An updated guideline on pharmacotherapy of obesity management in adults includes six new and seven revised recommendations, ...

AstraZeneca PLC thrives with $54B revenue and 14 blockbusters in 2024, fueled by oncology and rare disease growth. Click for ...

Drugmakers Sanofi, Eli Lilly, Novo Nordisk and AstraZeneca must face a lawsuit from two health centers accusing them of ...

Weight-loss drugs are expected to pull in more than $150 billion in industry-wide revenue by the early 2030s, thanks to the ...

US Health and Human Services is “winding down” its mRNA vaccine development and will instead fund other vaccine platforms ...

The objective response rate (ORR) was 32% with adagrasib versus 9% with docetaxel (OR 4.68, 95% CI 2.56-8.56, P <0.0001), ...

President Trump on Tuesday threatened to impose tariffs of up to 250 percent on pharmaceutical imports, the highest rate he’s ...

Note that some links may require registration or subscription. HHS Secretary Robert F. Kennedy Jr. announced that 22 projects ...

AstraZeneca PLC (NASDAQ:AZN) is among the 11 Best GLP-1 and Weight Loss Stocks to Invest in. AstraZeneca PLC (NASDAQ:AZN) and ...

Today’s Forbes CFO newsletter focuses on Aradhana Sarin’s journey from treating patients to becoming what she calls a ...

A new study from the Gray Faculty of Medical and Health Sciences at Tel Aviv University may mark a breakthrough in the ...

We will be totally self-sufficient for the supply of medicines to American patients.” AstraZeneca CEO Pascal Soriot on the ...